Term
| Diphenhydramine (Benadryl) |
|
Definition
| 1st Generation H1 Antihistamine |
|
|
Term
|
Definition
2nd Generation H1 Antihistamines
LESS Sedative/Anti-emetic |
|
|
Term
|
Definition
2nd Generation H1 Antihistamines
LESS Sedative/Anti-emetic |
|
|
Term
|
Definition
2nd Generation H1 Antihistamines
LESS Sedative/Anti-emetic |
|
|
Term
|
Definition
H2 Antihistamine
INTERFERES with CYP450
Used to decrease acid production
Treat Peptic Ulcers/GERD/etc.
Treat GERD, etc. |
|
|
Term
|
Definition
H2 Antihistamine
Used to decrease acid production
Treat Peptic Ulcers/GERD/etc. |
|
|
Term
|
Definition
H2 Antihistamine
Used to decrease acid production
Treat Peptic Ulcers/GERD/etc. |
|
|
Term
|
Definition
H2 Antihistamine
Used to decrease acid production
Treat Peptic Ulcers/GERD/etc. |
|
|
Term
|
Definition
Recombinant fusion protein - binds TNFR
Subcutaneous injection |
|
|
Term
|
Definition
Chimerical monoclonal Ab
Anti-TNFa
IV infusion |
|
|
Term
|
Definition
Recombinant human monoclonal Ab
Anti-TNFa
Subcutaneous injection |
|
|
Term
|
Definition
Endogenous protein
Recombinant IL-1R antagonist
Daily subcutaneous injection |
|
|
Term
|
Definition
Fusion protein
CTLA4 linked to IgG
Inhibits costimulation
IV |
|
|
Term
|
Definition
| PEGylated Fab of humanized Anti-TNFa Subcutaneous injection Treat Crohn's |
|
|
Term
|
Definition
| New Lupus drug Monoclonal Ab to BAFF/BLyS |
|
|
Term
|
Definition
|
|
Term
|
Definition
PGE1
Keeps open Ductus Arteriosus |
|
|
Term
|
Definition
PGI2
Pulmonary Hypertension |
|
|
Term
|
Definition
PGE1
Prevents NSAID-induced ulcers |
|
|
Term
| Hydrocortisone (Cortisol) |
|
Definition
SHORT Acting
Both GC & MC Activity |
|
|
Term
|
Definition
SHORT Acting GC
Inactive Topically (Prodrug) |
|
|
Term
|
Definition
INTERMEDIATE Acting GC
Inactive Topically (Prodrug) |
|
|
Term
|
Definition
|
|
Term
|
Definition
INTERMEDIATE Acting GC
NO MC Activity |
|
|
Term
|
Definition
INTERMEDIATE Acting GC
NO MC Activity
Acetonide form is 100x more active topically |
|
|
Term
|
Definition
LONG Acting GC
NO MC Activity |
|
|
Term
|
Definition
LONG Acting GC
NO MC Activity |
|
|
Term
|
Definition
Induction Therapy
Rabbit/horse Antibodies to Human T Cells
Prevent Acute Rejection |
|
|
Term
|
Definition
Induction Therapy
Anti-CD3 |
|
|
Term
|
Definition
Induction Therapy
Anti-IL-2R |
|
|
Term
|
Definition
Maintenance Therapy
Calcineurin Inhibitor
Prevents IL-2 transcription |
|
|
Term
|
Definition
Maintenance Therapy
Calcineurin Inhibitor (100x more potent)
Prevents IL-2 transcription |
|
|
Term
|
Definition
Maintenance Therapy
mTOR Inhibitor
Inhibit Lymphocyte Growth/Metabolism |
|
|
Term
|
Definition
Maintenance Therapy
mTOR Inhibitor
Inhibit Lymphocyte Growth/Metabolism |
|
|
Term
|
Definition
Cytotoxic Drug
Inhibits IMPD
Blocks de novo Purine Synthesis |
|
|
Term
|
Definition
Cytotoxic Drug
Metabolites inhibit de novo Purine Synthesis and DNA Synthesis |
|
|
Term
|
Definition
Irreversibly acetylates COX-1/2
Fully blocks COX-1
Partially blocks COX-2 (Anti-inflammatory 15-Epilipoxin formed) |
|
|
Term
|
Definition
NSAID
5-AminoSA
Treat IBS
Useful Topically |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
NSAID
Selective COX-2 Inhibitor
Treat arthritis pain/inflammation |
|
|
Term
|
Definition
NSAID
NOT Anti-inflammatory
No adverse side effects |
|
|
Term
|
Definition
NSAID
Propionic Acid Derivative |
|
|
Term
|
Definition
NSAID
Propionic Acid Derivative
Longer half-life than Ibuprofen |
|
|
Term
|
Definition
DMARD
1st line of treatment
Folate Inhibition
Inhibit DNA/Purine Synthesis |
|
|
Term
|
Definition
DMARD
1st line of treatment
Inhibits Pyrimidine Synthesis |
|
|
